Abstract
Thickening of the tubular basement membrane (TBM) occurs in diabetic nephropathy, but the effects of high glucose on the functional aspects of proximal tubular epithelial cells are not clearly understood. In the present study, we examined the effects of elevated glucose concentrations on (a) integrin expression by human proximal tubular epithelial cells (HK-2) and integrin-mediated interactions with type IV collagen (colIV) and laminin, major components of TBM; (b) the expression of matrixins/matrix metalloproteinases (MMPs), which is regulated by integrins; and (c) the expression of tissue inhibitors of metalloproteinases (TIMPs). HK-2 cells cultured in 25 mm glucose underwent a reduction of the expression of α3, β1, αvβ3, and α5 integrin subunits, with a concomitant increase of the α2 subunit, compared with cells grown in 5 mm glucose. Adhesion experiments demonstrated that high glucose led to increased cell adhesion on either colIV or laminin. Experiments of competition of adhesion using anti-integrin antibodies indicated that HK-2 cells in 5 mm glucose used mainly αvβ3 and α5β1 integrins to adhere to colIV, whereas in 25 mm glucose they additionally used α2β1. In the case of laminin, a β1-mediated adhesion was observed when HK-2 cells were in 5 mm glucose, whereas in 25 mm glucose, α2β1 and αvβ3 were also involved. Elevated glucose concentrations resulted in decreased expression of MMP-9 and MMP-2, whereas an increase in TIMP-1 and a decrease in TIMP-2 expression were observed. We also examined which integrins mediated the expression and secretion of matrixins MMP-2 and MMP-9. Ligation of α3β1 with mAbs resulted in induction of MMP-2 expression and secretion, whereas antibody ligation of αvβ3 led to down-regulation of MMP-9. The above data implicate integrins of proximal tubular epithelial cells in the regulation of MMPs and in the development of TBM thickening in diabetic nephropathy.
Similar content being viewed by others
Introduction
Basement membranes (BM) are specialized extracellular matrices (ECM) composed mainly of type IV collagen (colIV), laminin, entactin, and proteoglycans, which are considered to influence cellular phenotype and function (Paulsson, 1992). Interactions between cells and ECM are mediated by cell surface receptors, including integrins. Integrins are transmembrane receptors composed of two subunits, α and β, that heterodimerize in noncovalent association (Hynes, 1992; Ruoslahti, 1991). Each dimer can recognize several ECM proteins and each protein can bind with more than one dimer. On binding to ECM, integrins become clustered to the cell membrane, leading to the formation of focal adhesions where integrins link with the cytoskeleton. Focal adhesions also serve as a point for the activation of several signal transduction events (Boudreau and Jones, 1999; Chen et al, 1994; Clark and Brugge, 1995; Giancotti and Ruoslahti, 1999; Juliano and Haskill, 1993; Schlaepfer et al, 1994). Thus, integrins can transduce signals from the ECM to the cell interior that regulate various cellular functions, including adhesion, migration, proliferation, and gene expression (Boudreau and Jones, 1999; Clark and Brugge, 1995; Giancotti and Ruoslahti, 1999).
Diabetic nephropathy (DN) is a major complication in diabetes (Mauer et al, 1984), characterized by structural changes, including thickening of the glomerular (GBM) and tubular basement membranes (TBM), as well as expansion of the mesangial matrix (MM) (Brito et al, 1998; Lane et al, 1993; Rasch, 1984; Steffes et al, 1989, 1992; Ziyadeh, 1993).
Structural changes, which occur in diabetes, are due to increased deposition (synthesis and accumulation) and/or decreased degradation of ECM macromolecules. Studies have demonstrated that high glucose levels in vitro lead to increased expression and accumulation of ECM proteins in different renal cells (Anderson et al, 1996; Ayo et al, 1990, 1991; Danne et al, 1993; Phillips et al, 1997; Roth et al, 1993). Altered matrix expression in kidneys has also been observed in streptozotocin-diabetic rats (Wu et al 1997). In addition, nonenzymatic glycation (NEG) of BM proteins was reported to alter their structure and function in vitro (Anderson et al, 1992, 1993; Charonis and Tsilibary, 1992; Tsilibary et al, 1988), as well as interactions of these proteins with mesangial, endothelial, and glomerular epithelial cells (Anderson et al, 1994; Haitoglou et al, 1992; Krishnamurti et al, 1997).
Remodeling and degradation of ECM is mediated by matrixins (matrix metalloproteinases: MMPs), a family of zinc-dependent endopeptidases, which are involved in matrix turnover, in normal and disease processes (Birkedal-Hansen, 1995; Nagase and Woessner, 1999; Werb, 1997). For example, gelatinase A (72-kd gelatinase, or MMP-2) and B (92-kd gelatinase, or MMP-9) degrade collagen types IV, V, VII, and IX, gelatin, elastin, and fibronectin (Birkedal-Hansen, 1995; Matrisian, 1992). Matrixins are synthesized as proenzymes, secreted in an inactive form (proMMPs), and their proteolytic activities are controlled by inhibitors and activators. Proteolytic processing and activation of gelatinases may occur through their own proteolytic cleavage by other MMPs or proteases and, in addition, membrane-type MMPs (MT-MMPs) can activate proMMP-2 on the cell surface (Matrisian, 1992; Nagase and Woessner, 1999; Werb, 1997). Most cells express and secrete tissue inhibitors of metalloproteinases (TIMPs), TIMP-1 and TIMP-2, which preferentially bind MMP-9 and MMP-2, respectively (Matrisian, 1992; Nagase and Woessner, 1999; Werb, 1997). Integrins have been shown to mediate the expression of MMPs in various cell types (Ellerbroek et al, 1999; Langholz et al, 1995; Larjava et al, 1993; Seftor et al, 1992, 1993; Werb et al, 1989; Xie et al, 1998). In addition, cell surface proteolysis by MMPs may involve integrins directly (Brooks et al, 1996). Hence, integrins regulate matrix-related gene expression at least in part.
Different culture conditions may result in either enhanced or decreased expression of integrin receptors, in various physiologic and pathologic processes (Adams and Watt, 1990; Rozzo et al, 1993). For example, cells cultured in increased glucose concentrations were shown to undergo changes in integrin expression. Modulation of integrin expression resulted in altered adhesion to ECM proteins (Kitsiou et al, unpublished data; Roth et al, 1993.
In the present study we have used HPV-16 immortalized human proximal tubular epithelial cells (HK-2), to understand the mechanisms leading to TBM thickening, which occurs in DN, in addition to thickening of the GBM. HK-2 cells retain functional and morphologic characteristics of normal adult human proximal tubular epithelium (Ryan et al, 1994). We have examined the cellular and surface expression of integrin receptors in HK-2 cells cultured in normal and elevated glucose concentrations, and functional aspects of these cells related to integrins, including integrin-mediated interactions between cells and matrix macromolecules, such as colIV and laminin; and the expression and secretion of MMPs and TIMPs, proteins involved in basement membrane turnover. We present evidence that in HK-2 cells, the α3β1 integrin is a major receptor responsible for the induction of MMP-2 expression, whereas the αvβ3 integrin mediates down-regulation of MMP-9 in this system.
Results
Because integrin expression and function in diabetes might play a role in the development of related complications such as DN, we first examined the effect of high glucose concentration on the expression of integrins in HK-2 cells. Exposure of HK-2 cells to 25 mm glucose resulted in a decrease of α3 and β1 integrin mRNA levels by 30% and 36%, respectively, compared with cells grown in 5 mm glucose (Fig. 1). The glucose-induced decrease in mRNA of the examined integrin subunits was accompanied by decreased protein synthesis. Cells grown in 25 mm expressed 25% less α3 and 31% less β1 integrins (Fig. 2). In addition, Western blot analysis of α2, α5, αv, and β3 integrin revealed that cells cultured in 25 mm glucose expressed 24% less α5, 15% less αv, 20% less β3, and 29% more α2 integrins compared with control cells (Fig. 2).
Northern blot analysis of α3 and β1 integrin mRNA from HK-2 cells cultured in low or high glucose. A, Total RNA was isolated from cells cultured in 5 mm (L) or 25 mm (H) glucose. Twenty micrograms of each sample were probed with α3 and β1 DIG-labeled cDNA. Filters were rehybridized with a cDNA probe for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), as internal control, to verify RNA loads. B, Densitometric analysis of the mRNA level probed in A. Expression in 5 mm glucose was plotted as 100%. Each bar represents the mean ± standard deviation of three independent experiments. Differences were significant at p< 0.05.
Western blot analysis of integrin expression in HΚ-2 cells cultured in low or high glucose. A, Total protein was extracted from cells cultured in either 5 mm (L) or 25 mm (H) glucose. Equal amounts of total protein were analyzed on 7.5% SDS-PAGE under nonreducing conditions and immunoblotted with the appropriate dilution of polyclonal antibodies against integrin subunits. Blots were stripped and reprobed with anti-tubulin antibody, to verify protein loads, to which all quantitative data were normalized. B, Quantification of the protein content of each integrin subunit by scanning densitometry. Expression in 5 mm glucose was plotted as 100%. Each bar represents the mean ± standard deviation (sd) of three independent experiments. Differences were significant at p< 0.05.
We additionally used flow cytometry to determine whether glucose altered integrin expression on the cell surface. Specific mAbs against α3, α2, αvβ3, and β1 integrins were used as primary antibodies. As a control, we have used an anti-HLA mAb. As shown in Figure 3, exposure of cells to 25 mm glucose resulted in a significant decrease of cell surface–associated αvβ3 integrin. In addition, there was a similar decrease in the amount of cell surface α3 and β1 subunits in cells grown in 25 mm, compared with cells grown in 5 mm glucose. There was no effect on cell surface expression of the α2 integrin subunit, although there was a significant increase in the number of cells (approximately 40%) that were positive for this subunit in the presence of 25 mm glucose (data not shown).
FACS analysis of HK-2 cell-surface integrin expression. HK-2 cells cultured in media containing 5 mm (unshaded) or 25 mm (shaded) glucose were incubated with mAbs to α3 (P1B5), β1 (P5D2), and αvβ3 (Lm609) integrins, for 45 minutes on ice. Cells incubated in the absence of antibody or in the presence of anti-HLA mAb (W6/32) were used as negative or positive controls respectively. FITC-conjugated anti-mouse IgG was used as a secondary antibody. The first peaks (unshaded) represent cells incubated in the absence of primary antibody.
Because integrin receptors play an important role in cell-matrix interactions, we examined the effects of glucose on the ability of HK-2 cells to adhere to colIV and laminin, which are both components of their native TBM. Cells grown in either low (5 mm) or high (25 mm) glucose were allowed to adhere for 60 minutes to Engelbreth-Holm-Swarm (EHS)–derived colIV and laminin. Cells exposed to high glucose adhered more, both to colIV (Fig. 4A) and laminin (Fig. 4B), than cells grown in low glucose. The adhesion to both substrates was concentration-dependent up to 50 μg/ml, which represented the maximal observed adhesion. In addition, the data presented in Figure 4 suggest that HK-2 cells prefer colIV as a substrate, reaching up to 30% adhesion in 5 mm glucose, compared with 19% maximal adhesion to laminin. This preference was sustained in the presence of high glucose; up to 32% of HK-2 cells adhered to colIV and 22% adhered to laminin. Differences in adhesion to both substrates, in the presence of high glucose compared with low glucose, were statistically significant (p < 0.05) in all but the highest two concentrations, in the case of colIV.
Adhesion of HK-2 cells to Engelbreth-Holm-Swarm (EHS)–derived type IV collagen (colIV) (A) and laminin (B). [35S]-methionine–labeled HK-2 cells cultured in media containing 5 or 25 mm glucose were seeded in 96-well plates (5,000 cells/well) coated with increasing concentrations of colIV or laminin, and allowed to adhere for 60 minutes at 37° C. At the end of the incubation period, nonadherent cells were washed off, adherent cells were lysed, and radioactivity was quantitated. Bound counts were expressed as a percentage of total counts to give percentage adhesion. Nonspecific adhesion of cells to BSA, which was less than 1%, was subtracted from total adhesion in each case. Results were expressed as mean ± sd of six replicates, from three experiments. Differences were significant at p< 0.05, except for the highest two concentrations of colIV.
To examine the functional role of different integrin subunits in the binding of HK-2 cells to colIV and laminin under conditions of low and high glucose, we tested the adhesion of these cells to colIV and laminin in the presence of various blocking anti-integrin antibodies (Fig. 5, A and B). Antibodies were used at saturating concentrations, as determined by flow cytometry. In competition experiments, to achieve optimal antibody effects, we selected substrate concentrations that promoted approximately half-maximal binding of HK-2 (10 μg/ml for colIV, and 12 μg/ml for laminin). The data shown in Figure 5A indicate that mAbs directed against the α2 (P1E6), α5 (P1D6), αvβ3 (Lm609), and β1 (P5D2) integrin subunits competed for the adhesion between HK-2 cells and colIV. The mAb directed against α3 integrin subunit (P1B5) caused cell aggregation and was not effective in blocking adhesion. Adhesion in the presence of different antibodies was shown as the percentage of binding in the absence of antibodies, which was considered maximal (100%) adhesion, in each case. The extent of inhibition of adhesion by anti-α2, -αvβ3, -α5, and -β1 antibodies varied depending on glucose concentration. For example, in 5 mm glucose, anti-α2 antibodies resulted in less inhibition of adhesion (∼15%) compared with inhibition observed in 25 mm glucose (∼44%) (Fig. 5A). This correlated with the observed increase of α2 integrin in HK-2 cells grown in 25 mm, compared with cells grown in 5 mm glucose. However, in 5 mm glucose, anti-αvβ3 antibodies resulted in more inhibition of adhesion (∼69%) than in 25 mm glucose (∼50%) (Fig. 5A). This was consistent with the observed decrease of αvβ3 integrin in cells grown in 25 mm glucose compared with cells grown in 5 mm glucose. Anti-α5 and anti-β1 antibodies resulted in similar inhibition of adhesion, in either glucose concentration. These data indicate that under low glucose conditions, HK-2 cells primarily used αvβ3 and α5β1 integrins to bind colIV, and that α2β1 participated to a lesser extent in this case. When cells were grown in high glucose, the cells used αvβ3, α5β1, and α2β1 integrins to a similar extent, to adhere to colIV.
Inhibition of adhesion of HK-2 cells to colIV (A) and laminin (B) by anti-integrin antibodies in solid phase binding assays. [35S]-methionine–labeled HK-2 cells cultured in media containing 5 or 25 mm glucose were seeded in 96-well plates (5,000 cells/well) coated with 50 μl colIV (10 μg/ml) or 50 μl laminin (12 μg/ml), and allowed to adhere for 60 minutes at 37° C. Anti-integrin mAbs anti-α2 (P1E6), anti-α5 (P1D6), anti-αvβ3 (Lm609), and anti-β1 (P5D2) were added to the wells at a final concentration of 10 μg/ml before seeding with cells. Adhesion in the absence of mAb or in the presence of anti-HLA mAb (W6/32) was used as negative or positive control, respectively. At the end of the incubation period, nonadherent cells were washed off, adherent cells were lysed, and radioactivity was quantitated. Bound counts were expressed as a percentage of the counts bound in the absence of mAb, in each case. Results were expressed as mean ± sd of six replicates, from three experiments. Differences were significant at p< 0.05.
When laminin was used as a substrate, mAbs against the α2 and αvβ3 integrins resulted in less inhibition of adhesion in the presence of 5 mm glucose (∼15% and ∼22%, respectively) compared with 25 mm glucose (∼35% and ∼40%, respectively) (Fig. 5B); mAb against β1 integrin resulted in similar inhibition of cell adhesion, in either 5 or 25 mm glucose (∼45% and ∼51%, respectively) (Fig. 5B). mAb against α5 integrin did not inhibit adhesion in either glucose concentration, thus α5β1 was not involved in the binding of HK-2 cells to laminin. These data suggest that when HK-2 cells were grown in 5 mm glucose, adhesion to laminin was primarily mediated by a β1-bearing integrin, and to a lesser extent by αvβ3 integrin. When cells were cultured in 25 mm glucose, they used αvβ3 and additionally α2β1 to a greater extent compared with cells cultured in 5 mm glucose. mAb directed against HLA (W6/32), which was used as a control, had no effect on cell adhesion (Fig. 5, A and B).
MMPs are regulated by integrin-mediated pathways and also play a significant role in BM turnover; therefore we examined the presence and activity of MMPs in media from HK-2 cells cultured in 5 and 25 mm glucose. Using gelatin zymography of the conditioned media from cells, we detected enzymatic activity at two major bands corresponding to MMP-9 (92 kd) and MMP-2 (72 kd) (Fig. 6A). Densitometric analysis showed that conditioned media by HK-2 grown in 25 mm glucose contained 40% less of the MMP-9 and 39% less of MMP-2, respectively, compared with cells grown in 5 mm glucose (Fig. 6B).
Secretion of MMP-2 and MMP-9 by HK-2 cells cultured in 5 or 25 mm glucose. A, Aliquots of equal amounts of conditioned media based on cell numbers from cells cultured in 5 mm (L) or 25 mm (H) glucose, were concentrated and analyzed on 10% SDS-polyacrylamide gel containing 0.l% gelatin under nonreducing conditions. Gelatinolytic activity was detected as clear bands after incubation in enzyme buffer for 48 hours at 37° C and staining with Coomassie brilliant blue. B, Quantitation of the 92-kd form of MMP-9 and 72-kd form of MMP-2, by scanning densitometry. Gelatinolytic activity in 5 mm glucose was plotted as 100%. Each bar represents the mean ± sd of three independent experiments. Differences were significant at p< 0.05.
In sequence, Northern (Fig. 7, A and B) and Western blot analysis (Fig. 7, C and D) were performed to examine the expression and production of MMP-2 and, in addition, MMP-9 was examined by Western blotting in HK-2 cells cultured in the presence of 5 or 25 mm glucose. The mRNA of MMP-2 was decreased by 32% in cells cultured in 25 mm glucose compared with cells cultured in control (5 mm) glucose media (Fig. 7, A and B).
Effect of glucose on matrixins/matrix metalloproteinases (MMPs) secreted by HK-2 cells. A, Total RNA was isolated from cells cultured in 5 mm (L) or 25 mm (H) glucose. Twenty micrograms of each sample were probed with DIG-labeled cDNA for MMP-2 and rehybridized with a cDNA probe for GAPDH, as internal control, to verify RNA loads. C, Aliquots of equal amounts of conditioned media based on cell numbers from cells cultured in 5 mm (L) or 25 mm (H) glucose, were concentrated and analyzed on 10% SDS-polyacrylamide gel under reducing conditions. Electrophoretically transferred proteins were immunoblotted using primary antibodies against MMP-2 and MMP-9. Results from both Northern and Western blottings were analyzed by densitometry (B and D, respectively). Expression in 5 mm glucose was plotted as 100%. Each bar represents the mean ± sd of three independent experiments. Differences were significant at p< 0.05.
Western blot analysis of conditioned media from cells grown in 25 mm glucose demonstrated 40% less immunoreactivity at a band corresponding to the 72-kd form of MMP-2 compared with media conditioned by control cells (Fig. 7, C and D). Furthermore, the 92-kd form of MMP-9 was decreased by 38% in conditioned media from cells cultured in high glucose concentration in comparison with control cells (Fig. 7, C and D).
Because TIMPs regulate the activity of MMPs, we also examined the pattern of TIMPs expressed by cells grown in low and high glucose concentration. Northern blot analysis of TIMPs in cells cultured in 25 mm glucose revealed a 34% increase in TIMP-1 mRNA level, whereas the level of TIMP-2 mRNA showed a 38% decrease compared with control cells (Fig. 8, A and B). These changes were corroborated by Western blot analysis (Fig. 8, C and D). Cells grown in high glucose concentration revealed an increase by 35% for TIMP-1 protein in a single 28-kd band compared with cells grown in control media. In contrast, the single 22-kd TIMP-2 immunoreactive band was reduced by 35% in high glucose conditioned medium when compared with the control (Fig. 8, C and D).
Effect of glucose on the expression of TIMPs in HK-2 cells. A, Total RNA was isolated from cells cultured in 5 mm (L) or 25 mm (H) glucose. Twenty micrograms of each sample were probed with DIG-labeled cDNA for TIMP-1 or TIMP-2 and rehybridized with a cDNA probe for GAPDH, as internal control, to verify RNA loads. C, Aliquots of equal amounts of conditioned media based on cell numbers from cells cultured in 5 mm (L) or 25 mm (H) glucose were concentrated and analyzed on 10% SDS-polyacrylamide gel under reducing conditions. Electrophoretically transferred proteins were immunoblotted using primary antibodies against TIMP-1 and TIMP-2. Results from both Northern and Western blottings were analyzed by densitometry (B and D, respectively). Expression in 5 mm glucose was plotted as 100%. Each bar represents the mean ± sd of three independent experiments. Differences were significant at p< 0.05.
To examine the possible role of integrins in transcriptional regulation and secretion of MMPs in HK-2 cells, cells were cultured in the presence of mAbs against α3 (P1B5), β1 (P5D2), α3 and β1 simultaneously, αvβ3 (Lm609), and HLA (W6/32), which was used as a control, or in the absence of antibody, for 72 hours at 37° C as described in “Materials and Methods.” Conditioned media were collected for zymography. As shown in Figure 9, A and B, in the presence of either anti-α3 mAb or anti-β1 mAb, a 70% increase each in the secretion of MMP-2 was observed, whereas the combination of these two mAbs increased the secretion of MMP-2 approximately 2.4-fold in comparison with untreated cells or cells incubated with a control antibody (W6/32). mAbs against α3 and β1 integrins either alone or combined did not significantly affect the secretion of MMP-9. Additionally, we examined the effect of anti-α3 and anti-β1 mAbs on the expression of MMP-2 mRNA. Northern blot analysis revealed that in the presence of either mAb against α3 integrin or β1 integrin alone, an up-regulation of MMP-2 expression was observed, 70% and 60%, respectively. When cells were treated with a combination of mAb against α3 and β1 integrin subunits, an approximately 2-fold increase of MMP-2 mRNA was observed in comparison with untreated controls (Fig. 9, C and D). These data suggested a cooperative effect of the two different integrin subunits.
Effect of anti-α3 and anti-β1 antibodies on MMP-2 and MMP-9 expression and secretion. HK-2 cells were preincubated in the absence or presence of mAbs, anti-α3 integrin mAb (P1B5), anti-β1 integrin mAb (P5D2), a combination of both anti-(α3+β1) integrin mAbs, and anti-HLA mAb (W6/32) as a negative control, at a concentration of 40 μg/ml each in culture medium, for 30 minutes at 37° C, and then diluted 10-fold to a final concentration of 4 μg/ml each and cultured for 48 hours. The medium was removed, the flasks were washed with PBS, and cells were incubated for 24 hours in medium lacking BPE, containing or not 4 μg/ml of each mAb. At the end of the 24-hour incubation period, aliquots of equal amounts of conditioned media based on cell numbers were concentrated and analyzed by gelatin zymography (A) and 20 μg of total RNA isolated from cells in each condition were probed with DIG-labeled cDNA for MMP-2 and rehybridized with a cDNA probe for GAPDH, as internal control, to verify RNA loads (C). Results from both gelatin zymography and Northern blotting were analyzed by densitometry (Panels B and D, respectively). Gelatinolytic activity and expression in the absence of antibody (control) were plotted as 100%. Each bar represents the mean ± sd of three independent experiments. Differences were significant at p < 0.05.
Incubation of HK-2 in the presence of mAb against the αvβ3 integrin resulted in a dramatic decrease (approximately 6.5-fold) of MMP-9 secretion in zymography (Fig. 10, A and B) and Western blot analysis (Fig. 10, C and D). In contrast, MMP-2 secretion was unaltered by treatment of the cells with mAb against the αvβ3 integrin, in comparison with that of cells incubated with a control antibody (anti-HLA) or in the absence of antibody (Fig. 10A). These observations suggested that αvβ3 participates in down-regulation of MMP-9.
Effect of anti-αvβ3 antibody on MMP-2 and MMP-9 secretion. HK-2 cells were preincubated with mAbs, anti-αvβ3 integrin mAb (Lm609), anti-HLA mAb (W6/32), at a concentration of 40 μg/ml each in culture medium, for 30 minutes at 37° C, and then diluted 10-fold to a final concentration of 4 μg/ml each, and cultured for 48 hours. As an additional control, the cells were incubated in the absence of antibodies. At the end of the incubation, the medium was removed, the flasks were washed with 1 × PBS, and cells were incubated for 24 hours in medium lacking BPE, containing or not 4 μg/ml of each mAb. After 24 hours, aliquots of equal amounts of conditioned media based on cell numbers were concentrated and analyzed by gelatin zymography (A) and Western blotting (C). Results from gelatin zymography and Western blotting were analyzed by densitometry (B and D, respectively). Gelatinolytic activity and expression in the absence of antibody (control) were plotted as 100%. Each bar represents the mean ± sd of three independent experiments. Differences were significant at p< 0.05.
Discussion
In diabetes, hyperglycemia alters cell behavior in vitro or in situ as a result of elevated glucose concentrations or other mechanisms. In the present report we provide evidence that increased glucose levels affect cell behavior by modulating the expression and function of integrins in cultured human proximal tubular epithelial cells, the HK-2 cells. The observed changes were not due to osmotic effects of glucose, because incubation of HK-2 cells in the presence of L-glucose did not result in integrin differences from control cells, which were grown in 5 mm glucose, by either FACs or Western analysis (data not shown). In addition, in a different report, L-glucose had no effect in cultured primary tubular epithelial cells (Park and Han, 2002).
HK-2 cells grown in normal (5 mm) glucose concentration mainly expressed α3β1 and αvβ3 integrins. These integrins were reported to be present in situ in kidney proximal tubules (Simon and McDonald, 1990), as well as in a primate kidney tubular epithelial cell line (Gailit et al, 1993). In renal tubular epithelial cells, the α3β1 integrin mediates binding to laminin and fibronectin and the αvβ3 integrin binds to collagen and fibronectin (Goligorsky et al, 1993). Both the α3β1 and αvβ3 integrins of HK-2 cells bind to tubulointerstitial nephritis antigen (TIN-ag), a specialized component of TBM (Chen et al, 1996). In addition, HK-2 cells express α5 and α2 integrins, which also mediate binding to collagens, laminin, and fibronectin. In our experiments, when the cells were cultured in the presence of 25 mm glucose, a decrease of the α3, α5, αvβ3, and β1 integrin subunits was observed, with a concomitant increase in α2 subunit compared with control cells. This “integrin reversal” has also been reported in other cell types. Human mesangial and glomerular epithelial cells grown in 25 mm glucose revealed an increased expression of some integrins with concomitant decrease of others, which led to altered functions of these integrins, including impaired interactions with colIV (Kitsiou et al, unpublished data. In addition, modulation of integrin expression has been reported to occur in different stages of cell differentiation (Adams and Watt, 1990; Rozzo et al, 1993), in human glomerular diseases (Hafdi et al, 2000), and in human umbilical vein endothelial cells cultured in high glucose (Roth et al, 1993). In these situations, cells responded to the altered milieu by modulating their integrin pattern.
The observed modulation of integrin expression in HK-2 cells reflected altered interactions with major TBM macromolecules, such as colIV and laminin. HK-2 cells grown in high glucose (25 mm) adhered more to both substrates than cells grown in low glucose (5 mm), in solid phase adhesion assays. Another cell type, glomerular epithelial cells, were observed to adhere to a lesser extent to BM substrates in the presence of high glucose (Kitsiou et al, unpublished data). Thus, modulation of adhesion in the presence of increased glucose concentrations is cell type–specific. Moreover, cells preferentially adhered to colIV compared with laminin for both concentrations of glucose.
HK-2 cells used different integrins to bind to colIV and laminin and, in addition, in the presence of high glucose the integrin repertoire involved in the binding events differed, compared with the binding in low glucose. Experiments of inhibition of adhesion using anti-integrin mAbs demonstrated that HK-2 cells grown under normal glucose concentrations used primarily the αvβ3 integrin for adhesion to colIV. In addition, these cells apparently used β1 combined with α subunits, including α5β1, but to a lesser extent than αvβ3. In high glucose concentrations, the cells used αvβ3, albeit to a lesser extent than in 5 mm glucose, as well as α5β1 and α2β1. This was suggested by the extent of inhibition of cell adhesion to colIV in high glucose, which corroborated the observed changes of αvβ3 and α2β1 integrins compared with the control, because elevated glucose resulted in increased expression of α2 with a concomitant decrease of αvβ3 integrins. Inhibition experiments on laminin substrates revealed that β1-mediated adhesion in 5 mm glucose did not primarily involve the α5 or α2 integrin subunits, because the observed inhibition in the presence of anti-α5 or anti-α2 antibodies was minimal. It is possible that other “α” integrin subunits, such as the α3 may be responsible for this interaction in proximal tubular epithelial cells, as was reported previously (Goligorsky et al, 1993). mAb against αvβ3 resulted in a small inhibition of adhesion, suggesting that this integrin should play a minor role in HK-2 cell adhesion to laminin. In the presence of high glucose, in addition to β1, α2 and αvβ3 integrins were apparently used for adhesion to laminin. The above data indicate that glucose-induced alteration of integrin expression in HK-2 cells was accompanied by altered integrin functions, including cell-matrix interactions. Our observations suggest that different integrin subunits play a dominant role in the binding of HK-2 cells to colIV and laminin, depending on glucose concentration. If similar changes occur in situ in diabetes, then altered interactions with matrix components could be responsible for altering integrin-mediated intracellular signaling and matrix-related gene expression.
Thickening of TBM is one of the characteristic changes occurring in DN (Brito et al, 1998), possibly due to increased deposition (synthesis and accumulation) and/or decreased degradation of ECM macromolecules (Lane et al, 1993; Phillips et al, 1997; Ziyadeh, 1993). In this respect, our results demonstrated that HK-2 cells grown in 25 mm glucose underwent changes resulting in altered expression and/or activity of matrixins/MMPs. Exposure of cells to elevated glucose levels resulted in a down-regulation of both MMP-2 and MMP-9 enzymes with a concomitant up-regulation of the inhibitor TIMP-1, which is specific for MMP-9. The observed decrease of TIMP-2, specific inhibitor for MMP-2, may represent a balancing cellular effect to decreased MMP levels. Similar observations have been reported for other cell types; increased glucose concentrations resulted in altered expression of matrix, MMPs and TIMPs (Anderson et al, 1996; Kitsiou et al, unpublished data, and kidneys of streptozotocin-diabetic rats (Wu et al, 1997). Our results indicate that high glucose levels cause changes in HK-2 function, which in turn could contribute to the decreased degradation of the ECM proteins. The long-term effect could be matrix accumulation, which is typical of the thickening of TBM in DN.
It has been previously reported that integrins may have a significant role in MMP-dependent degradation of ECM, regulating the expression and activation of these enzymes. In synovial fibroblasts, α5β1 and α4β1 were shown to regulate MMP-2 and stromelysin expression (Huhtala et al, 1995; Werb et al, 1989), and α2β1 integrin was observed to mediate the induction of MMP-1 in fibroblasts (Langholz et al, 1995). Expression and secretion of MMP-2 was modulated by αvβ3 and α5β1 integrins (Seftor et al, 1992, 1993), and expression of αvβ3 correlated with activation of MMP-2 in human melanoma cells (Hofmann et al, 2000). In addition, the α2β1 integrin was reported as a positive regulator of the expression of MMP-1 in osteosarcoma cells (Riikonen et al, 1995), and α3β1 integrin induced the expression of MMP-9 in human and mouse keratinocytes (DiPersio et al, 2000; Larjava et al, 1993). Chintala et al (1996) have reported that antibody-induced ligation of α3β1 and α5β1 integrin enhanced the secretion of MMP-2 in glioblastoma cells, whereas α3β1 and α5β1 integrins may be involved in the induction of expression/secretion and activation of MMP-2 in rhabdomyosarcoma and fibrosarcoma cells, respectively (Kubota et al, 1997; Stanton et al, 1998). Furthermore, several other recent reports have implicated α3β1, α4β1, α5β1, and αvβ6 integrins in the regulation of MMP-2 and MMP-9 expression and secretion in various cell types (Agrez et al, 1999; Esparza et al, 1999; Sugiura and Berditchevski, 1999; Xie et al, 1998). Our results demonstrated that ligation of α3β1 integrin with mAbs, which in this case mimicked the effect of integrin ligands, resulted in the induction of the expression and secretion of matrixin MMP-2; mAbs against αvβ3 had no significant effect. This integrin-mediated mechanism of MMP-2 regulation of expression should involve FAK phosphorylation (Kitsiou et al, unpublished data), as well as MAPK activation, as we and others reported elsewhere (Krishnamurti et al, 1997, Tremble et al, 1995). In this respect, the observed decrease of α3β1 in high glucose should also account for the decreased expression of MMP-2, at least in part. In contrast, ligation of αvβ3 but not α3β1 resulted in an impressive down-regulation of MMP-9 secretion. The mechanism by which ligation of αvβ3 resulted in down-regulation of MMP-9 is not fully understood. However, regulation of gene expression by integrins involves multiple and complex mechanisms in which signals from integrins and growth factor receptors and signals involving PI-3 kinase and other kinases cross talk, resulting in positive or negative regulation (Giancotti and Ruoslahti, 1999). In the case of T-lymphocytes, fibronectin induced the expression of MMP-2 and MMP-9 via α4-, α5-, and αv-bearing integrins and transmitted both stimulatory (through Src-type tyrosine kinase) and inhibitory signals (through Ras/MAPK signaling) for both these matrixins, suggesting that their relative predominance should be regulated by additional stimuli (Esparza et al, 1999). In HK-2 cells, α3β1 and αvβ3 integrins apparently represent major receptors with opposite effects on the expression/secretion of MMP-2 and MMP-9, although the expression of these two matrixins may be additionally regulated by other integrins or different receptors.
In conclusion, our results indicate that glucose-induced modulation of integrin expression resulted in changes in HK-2 integrin-related functions in vitro, which in turn could contribute to the decreased degradation of matrix proteins. The long-term effect, in situ, could be matrix accumulation, which is typical of the thickening of the TBM in DN. The evidence presented in this report suggests that α3β1 and αvβ3 integrins are receptors involved in differential regulation of MMP-2 expression and secretion (up-regulation) and MMP-9 secretion (down-regulation), respectively, and that glucose-induced alterations of integrins and integrin-related functions in cells grown in high glucose concentrations may be mechanistically linked to the observed alterations in the expression and secretion of matrixins.
Materials and Methods
Cell Lines and Culture Conditions
Human proximal tubular epithelial cells, HPV-16 immortalized (HK-2) (Ryan et al, 1994), were cultured in keratinocyte serum-free medium (KSF-M; Gibco BRL Life Technologies, Grand Island, New York), supplemented with epidermal growth factor (EGF; 10 ng/ml) and bovine pituitary extract (BPE; 40 μg/ml), in either 5 or 25 mm D-glucose, at 37° C in an environment of 95% air and 5% CO2. Cells were released from their tissue culture flasks for passaging or use in experiments by treatment with 0.05% trypsin/1 mm EDTA. For experiments, cells were cultured for at least three passages. For the adhesion and inhibition of adhesion experiments, HK-2 cells were grown in either 5 or 25 mm glucose in T-25 flasks until 75% to 80% confluency was reached and were metabolically labeled for 18 hours with 0.15 mCi of [35S]-methionine (Amersham, London, England) per T-25 flask, in medium lacking BPE.
For zymography and Western blotting analysis of conditioned media, cells (2 × 106) were cultured in either 5 or 25 mm glucose media in 75 cm2-tissue culture flasks for 48 hours. The medium was then removed, the flasks were washed three times with PBS, and cells were incubated for 24 hours in 10 ml medium lacking BPE. At the end of the 24-hour incubation period, the conditioned media were transferred to 15 ml conical tubes, centrifuged to remove cells and cell fragments, supplemented with 1 mm Na2EDTA and 0.02% sodium azide, and stored at −20° C for further use.
Antibodies
Rabbit anti-human polyclonal antibodies to the integrin subunits (α2, α3, α5, αv, β1, and β3) and mouse anti-human mAbs against α2 (P1E6), α3 (P1B5), α5 (P1D6), αvβ3 (Lm609), and β1 (P5D2) integrin subunits, which have been previously characterized (Wayner et al, 1991, 1993), were obtained from Chemicon International (Temecula, California). Rabbit polyclonal antibodies against collagenases MMP-2 (Ab45) and MMP-9 (Ab110) and their inhibitors TIMP-1 and TIMP-2 were kindly provided by Dr. Stetler-Stevenson. Anti-HLA mAb (W6/32) was used as control (W6/32, HB95; American Type Culture Collection, Rockville, Maryland). Mouse anti-tubulin mAb was purchased from Sigma (St. Louis, Missouri). Fluorescein-conjugated goat anti-mouse IgG was obtained from Cappel (ICN Pharmaceuticals, Frankfurt, Germany).
Preparation of Substrates
ColIV and laminin were isolated from EHS tumor (Orkin et al, 1977), grown subcutaneously in lathyritic mice, and purified according to previously described protocols (Charonis et al, 1985; Kleinman et al, 1982). Before use, colIV was dialyzed against PBS (pH 7.4), and cleared of large aggregates by centrifugation at 14,000 rpm for 30 minutes at 4° C. Protein concentration was determined using the method of Waddell (Waddell, 1956; Wolf, 1983). Laminin was dialyzed twice against 50 mm Tris-HCl (pH 7.6), overnight against 50 mm Tris-HCl, 1 m CaCl2 (pH 7.6), and again with 50 mm Tris-HCl (pH 7.6). Laminin concentration was determined by the method of Bradford using a Coomassie Plus Protein Assay Reagent Kit (Pierce, Rockford, Illinois).
Cell Adhesion to ColIV and Laminin
Ninety-six–well microtiter plates (Microlon 600; Greiner Japan, Tokyo, Japan) were coated with 50 μl of colIV and laminin in serial dilutions starting from 100 μg/ml. The microtiter plates were allowed to evaporate at 29° C to dryness. To block the remaining reactive sites, the plates were treated with 200 μl of BSA at 2 mg/ml in PBS (pH 7.4) and incubated for 2 hours at 37° C. Plates were then washed once with 200 μl of sterile PBS and immediately used for experiments. Labeled cells were detached from the flasks by incubation with trypsin, washed twice with DMEM, and resuspended in binding buffer (DMEM, 2 mg/ml BSA, 15 mm HEPES, pH 7.5). Fifty microliters of cell suspension, containing 5,000 cells, were added per well and the plates were incubated for 60 minutes at 37° C in a humidified incubator. After incubation, the cells were washed three times with 200 μl of binding buffer to remove nonadherent cells and 100 μl of lysis buffer (0.5 NaOH, 1% SDS) were added to each well. The lysate was transferred to scintillation vials and counted. Total input counts per minute was 50 μl of cell suspension (5,000 cells) added to scintillation vials. The data were expressed as a percentage of the total input counts per minute to give percentage adhesion. Nonspecific adhesion of cells to BSA was subtracted from the percentage adhesion to adhesive proteins. Cell adhesion assays were performed at least three times in hexaplicate.
Inhibition of Cell Adhesion to ColIV and Laminin
Ninety-six–well microtiter plates (Microlon 600; Greiner) were coated with 50 μl of colIV and laminin at 10 μg/ml and 12 μg/ml, respectively, overnight at 29° C. The plates were blocked with 200 μl of 2 mg/ml BSA/PBS for 2 hours at 37° C, washed once with sterile PBS, and then 10 μg/ml of mAb to integrin subunit or mAb to HLA were added to each well at a final volume of 100 μl/well, followed immediately by the cells. Cells were processed as for the adhesion assay and 50 μl of cell suspension in binding buffer (5,000 cells) were added to each well. Cells were allowed to adhere for 60 minutes at 37° C in a humidified incubator, then washed three times with binding buffer to remove nonadherent cells, and bound cells were quantified as described previously. The concentration of antibodies used in inhibition assays was well above the saturating concentration as determined by flow cytometry. Data were expressed as the percentage of adhesion observed in the absence of antibody. Inhibition experiments were performed at least three times in hexaplicate.
FACS
Expression of integrin subunits in cultured HK-2 cells was evaluated by indirect immunofluorescence staining and FACS. Briefly, HK-2 cells were released from confluent monolayer cultures with trypsin, washed, and resuspended in FACS buffer (2% FCS, 0.02% sodium azide in PBS). Cells (5 × 105) were added to each vial and incubated with mAbs to α2, α3, αvβ3, β1, and HLA (used as a control) for 45 minutes on ice and washed twice with 2 ml FACS buffer. Then, goat anti-mouse IgG-conjugated with FITC was added in a total volume of 0.1 ml FACS buffer, and cells were incubated for 45 minutes on ice. After washing twice with FACS buffer, the cells were fixed with 1 ml of 1% formaldehyde in PBS. Analysis was performed using CELL QUEST software on a FACScan (Becton Dickinson, Franklin Lakes, New Jersey). Positive fluorescence was determined on a four-decade log scale and fluorescence (log F1) was expressed as the mean channel number of 10,000 cells.
Incubation of Cells with Antibodies
HK-2 cells were detached from confluent monolayer cultures by trypsin treatment, collected by centrifugation, and resuspended in culture medium (2.5 × 106 cells/ml) in normal glucose concentration (5 mm). After addition of anti-integrin mAb at a concentration of 40 μg/ml each, cells were preincubated for 30 minutes at 37° C, and then diluted 10-fold to a final concentrations of 4 μg/ml each, or in the absence of antibody, and cultured for 48 hours. The medium was then removed, the flasks were washed three times with PBS, and cells were incubated for 24 hours in medium lacking BPE containing or not 4 μg/ml of each mAb. After 24 hours, the conditioned media were collected for zymography and Western blotting, and the cells counted and used for RNA isolation.
cDNA Probes
The following probes were used: pBSK plasmids containing 1.8-kb PstI fragment from α3 cDNA integrin subunit, 299-bp EcoRI fragment from MMP-2 cDNA, 490-bp and 600-bp EcoRI/BamHI fragments from TIMP-2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA, and a 450-bp EcoRI/HindIII fragment from TIMP-1 cDNA. Finally, a 1.3-kb fragment of β1 integrin subunit was used, which was cloned into PECE plasmid at a BglII site. CsCl purified plasmids containing the cDNA inserts were isolated and digested by appropriate restriction enzymes. The cDNA inserts were separated by electrophoresis in 1% low-melting agarose gels and they were purified from agarose slices by phenol-chloroform extraction. Inserts were labeled with digoxigenin-11dUTP using the DIG-High Prime DNA Labeling and Detection Starter Kit II (Boehringer-Mannheim, Mannheim, Germany).
Total RNA Isolation and Northern Blot Analysis
Total cellular RNA was isolated from HK-2 cells cultured in either low (5 mm) or high (25 mm) glucose, as well as in the presence of anti-integrin mAbs, using the RNAgents Total RNA Isolation System (Promega, Southampton, England) according to the manufacturer’s instructions. The concentration and purity of RNA was determined spectrophotometrically by reading the absorbance at 260 nm and 280 nm. Twenty micrograms of RNA from each sample were denatured in 1 × MOPS buffer (20 mm 3-N-morpholino-propanesulphonic acid, 8 mm sodium acetate, 1 mm EDTA, pH 7) containing 2.2 m formaldehyde and 50% formamide by heating at 65° C for 15 minutes. Samples were then mixed with 10x loading buffer (50% glycerol, 0.25% bromophenol blue, 0.25% xylene cyanol FF, 1 mm EDTA) in 1 × final concentration, and separated in 1% agarose gel containing formaldehyde for 3 hours at 4 Volts/cm in 1 × MOPS running buffer containing 2.2 m formaldehyde. RNAs were transferred overnight from the gel to Hybond-N+ nylon membrane (Amersham) by capillary elution. The membranes were incubated in prehybridization solution (7% SDS, 50% formamide, 5 × SSC, 50 mm sodium phosphate, 0.1% L-Lauroylsarcosine, 100 μg/ml sonicated salmon sperm DNA, and 2% blocking reagent) for 2 hours at 42° C. Hybridizations were performed overnight at 42° C in the same solution containing 50 ng/ml of the appropriate denaturated DIG-labeled cDNA probe. After hybridization, filters were washed 2 × 15 minutes in 2x SSC, 0.1% SDS at room temperature, and 2 × 15 minutes in 0.2x SSC, 0.1% SDS at 60° C. Signal detection was performed using the DIG Luminescent Detection Kit (Boehringer-Mannheim), according to the manufacturer’s protocol. Filters were stripped of previous probes in 2x SSC, 0.5% SDS for 20 minutes by heating at 90° C and reprobed with GAPDH probe as internal control. The resulting measurements were corrected for GAPDH mRNA levels.
Gelatin Zymography
Gelatin zymography was performed as previously described (Anderson et al, 1996). Briefly, aliquots of equal amounts of conditioned media, based on cell numbers determined at the time of harvest, were concentrated and subjected under nonreducing conditions and without boiling to 10% SDS-polyacrylamide gels containing 0.1% gelatin. After electrophoresis, the gel was washed three times for 30 minutes with 50 mm Tris-HCl, pH 7.5, 5 mm CaCl2, 1 μm ZnCl2, 2.5% Triton X-100, and 0.02% NaN3 at room temperature to remove SDS. The gel was then incubated in the same buffer excluding Triton X-100 for 48 hours at 37° C. After staining with Coomassie brilliant blue R-250 for 3 hours and destaining in water, gelatin-degrading activity was visualized as clear bands against a dark blue background.
Total Protein Extraction
HK-2 cells cultured in either low or high glucose media were detached from flasks by treatment with trypsin, washed three times with PBS (pH 7.4), and lysed in a buffer containing 1% Triton X-100, 1 mm CaCl2, a cocktail of protease inhibitors (P8340; Sigma), 1 mm PMSF, 1 mm NEM in PBS (pH 7.4) for 60 minutes at 4° C. Insoluble material was removed by centrifugation at 13,000 rpm for 30 minutes at 4° C. Protein estimation was done by the method of Bradford using a Coomassie Plus Protein Assay Reagent Kit (Pierce).
Western Blotting
Equal protein amounts from cell lysates were separated by 7.5% SDS-polyacrylamide gel electrophoresis, under nonreducing conditions according to the method of Laemmli (1970). For MMPs and TIMPs, equal amounts of condition media (based on cell number) were concentrated and separated by 10% SDS-PAGE, under reducing conditions. After electrophoresis, proteins were transferred to Hybond-ECL nitrocellulose membrane (Amersham) by electroblotting (Towbin et al, 1979) and blots were blocked for 2 hours at room temperature with 5% nonfat milk in TBS, with 0.1% Tween-20. Membranes were then incubated overnight at 4° C with the appropriate dilutions of polyclonal antibodies or mAb against tubulin (used as internal control), in the same buffer without Tween-20. After washing with TBS/0.1% Tween-20, membranes were incubated for 1 hour at room temperature with peroxidase (HRP)-conjugated anti-rabbit or anti-mouse immunoglobulins (Amersham) as secondary antibodies. Bound antibody was detected by ECL Western blotting detection system (Amersham).
Statistical Analysis
Mean values were derived from experiments performed in triplicate. These values were compared using the Student t test. In adhesion experiments, a single-factor analysis of variance (ANOVA) was performed on the results for cells grown in either 5 or 25 mm glucose, in each substrate concentration. A p value of < 0.05 was considered statistically significant.
Densitometric Analysis
Images of Western and Northern blots as well as zymograms were analyzed using image processing software (Bioprofil Vilber Loumart, Paris, France).
References
Adams JC and Watt FM (1990). Changes in keratinocyte adhesion during terminal differentiation: Reduction in fibronectin binding precedes α5β1 integrin loss from the cell surface. Cell 63: 425–435.
Agrez M, Xinhua G, Turton J, Meldrum C, Niu J, Antalis T, and Howard EW (1999). The αvβ6 integrin induces gelatinase B secretion in colon cancer cells. Int J Cancer 81: 90–97.
Anderson SS, Charonis AS, Kim Y, and Tsilibary EC (1992). Altered basement membrane structure and interaction with kidney mesangial cells following nonenzymatic glycosylation. J Am Soc Nephrol 3: 625–629.
Anderson SS, Kim Y, and Tsilibary EC (1994). Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation. Kidney Int 46: 1359–1367.
Anderson SS, Tsilibary EC, and Charonis AS (1993). Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane. J Clin Invest 92: 3045–3052.
Anderson SS, Wu K, Nagase H, Stetler-Stevenson W, Kim Y, and Tsilibary EC (1996). Effect of matrix glycation on express of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells. Cell Adhes Commun 4: 89–101.
Ayo SH, Radnik RA, Garoni JA, Glass WR, and Kreisberg JI (1990). High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136: 1339–1348.
Ayo SH, Radnik RA, Glass WR, Garoni JA, Rampt ER, Appling DR, and Kreisberg JI (1991). Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260: F185–F191.
Birkedal-Hansen H (1995). Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7: 728–735.
Boudreau NJ and Jones PL (1999). Extracellular matrix and integrin signaling: The shape of things to come. Biochem J 339: 481–488.
Brito PL, Fioretto P, Drummond K, Kim Y, Steffes MW, Basgen JM, Sisson-Ross S, and Mauer M (1998). Proximal tubular basement membrane width in insulin- dependent diabetes mellitus. Kidney Int 53: 754–761.
Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, and Cheresh DA (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85: 683–693.
Charonis AS and Tsilibary EC (1992). Structural and functional changes in laminin and type IV collagen after nonenzymatic glycosylation. Diabetes 41 (Suppl 2): 49–51.
Charonis AS, Tsilibary EC, Yurchenco PD, and Furthmayr H (1985). Binding of laminin to type IV collagen: A morphological study. J Cell Biol 100: 1848–1853.
Chen Q, Kinch MS, Lin TH, Burridge K, and Juliano RL (1994). Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J Biol Chem 269: 26602–26605.
Chen Y, Krishnamurti U, Wayner EA, Michael AF, and Charonis AS (1996). Receptors in proximal tubular epithelial cells for tubulointerstitial nephritis antigen. Kidney Int 49: 153–157.
Chintala SK, Sawaya R, Gokaslan ZL, and Rao JS (1996). Modulation of matrix metalloprotease-2 and invasion in human glioma cells by alpha 3 beta 1 integrin. Cancer Lett 103: 201–208.
Clark EA and Brugge JS (1995). Integrins and signal transduction pathways: The road taken. Science 268: 233–239.
Danne T, Spiro MJ, and Spiro RG (1993). Effect of high glucose on type IV collagen production by cultured glomerular epithelial cells, endothelial and mesangial cells. Diabetes 42: 170–177.
DiPersio CM, Shao M, Di Costanzo L, Kreidberg JA, and Hynes RO (2000). Mouse keratinocytes immortalized with large T antigen acquire α3β1 integrin dependent secretion of MMP-9/gelatinase B. J Cell Sci 113: 2909–2921.
Ellerbroek SM, Fishman DA, Kearns AS, Bafetti LM, and Stack MS (1999). Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. Cancer Res 59: 1635–1641.
Esparza J, Vilardell C, Calvo J, Juan M, Vives J, Urbano-Marquez A, Yague J, and Cid MC (1999). Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through Ras/MAP kinase signaling pathway. Blood 49: 2754–2766.
Gailit J, Colflesh D, Rabiner I, Simone J, and Goligorsky MS (1993). Redistribution and dysfunction of integrins in cultured renal epithelial cells exposed to oxidative stress. Am J Physiol 264: F149–F157.
Giancotti FG and Ruoslahti E (1999). Integrin signaling. Science 285: 1028–1032.
Goligorsky MS, Lieberthal W, Racusen L, and Simon EE (1993). Integrin receptors in renal tubular epithelium: New insights into pathophysiology of acute renal failure. Am J Physiol 264 (1Pt2):F1–F8.
Hafdi Z, Lesavre P, Nejjari M, Halbwachs-Mecarelli L, Droz D, and Noel LH (2000). Distribution of alphavbeta3, alphavbeta5 integrins and the integrin associated protein-IAP (CD47) in human glomerular diseases. Cell Adhes Commun 7: 441–451.
Haitoglou CS, Tsilibary EC, Brownlee M, and Charonis AS (1992). Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J Biol Chem 267: 12404–12407.
Hofmann UB, Westphall JR, Van Kraats AA, Ruiter DJ, and Van Muijen GNP (2000). Expression of integrin αvβ3 correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells. Int J Cancer 87: 12–19.
Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, and Damsky CH (1995). Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129: 867–879.
Hynes RO (1992). Integrins: Versatility, modulation and signaling in cell adhesion. Cell 69: 11–25.
Juliano RL and Haskill S (1993). Signal transduction from the extracellular matrix. J Cell Biol 120: 577–585.
Kleinman HK, McGarvey ML, Liotta LA, Gehron Robey P, Tryggvason K, and Martin GR (1982). Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21: 6188–6193.
Krishnamurti U, Rondeau E, Sraer JD, Michael AF, and Tsilibary EC (1997). Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix. J Biol Chem 272: 27966–27970.
Kubota S, Ito H, Ishibashi Y, and Seyama Y (1997). Anti-α3 integrin antibody induces the activated form of matrix metalloprotease-2 (MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells. Int J Cancer 70: 106–111.
Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
Lane PH, Steffes MW, Fioretto P, and Mauer SM (1993). Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 43: 661–667.
Langholz O, Rockel D, Mauch C, Kozlowska E, Bank I, Krieg T, and Eckes B (1995). Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by α1β1 and α2β1 integrins. J Cell Biol 131: 1903–1915.
Larjava H, Lyons JG, Salo T, Makela M, Koivisto L, Birkedal-Hansen H, Akiyama SK, Yamada KM, and Heino J (1993). Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J Cell Physiol 157: 190–200.
Leehey D, Song RH, Alavi N, and Singh AK (1995). Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 44: 929–935.
Matrisian LM (1992). The matrix-degrading metalloproteinases. Bioessays 14: 455–463.
Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, and Goetz FC (1984). Structural-functional relationship in diabetic nephropathy. J Clin Invest 74: 1143–1155.
Nagase H and Woessner JF (1999). Matrix metalloproteinases. J Biol Chem 274: 21491–21494.
Orkin RW, Gehron P, Goodwin EB, Martin GR, Valentine T, and Swarm R (1977). A murine tumor producing a matrix of basement membrane. J Exp Med 145: 204–220.
Park SH and Han HJ (2002). The mechanism of angiotensin II binding down-regulation by high glucose in primary renal proximal tubule cells. Am J Physiol Renal Physiol 282: F228–237.
Paulsson M (1992). Basement membrane proteins: Structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 27: 93–127.
Phillips AO, Steadman R, Morrisey K, Martin J, Eynstone L, and Williams JD (1997). Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation. Kidney Int 52: 973–984.
Rasch R (1984). Tubular lesions in streptozotocin diabetic rats. Diabetologia 27: 32–37.
Riikonen T, Westermarck J, Koivisto L, Broberg A, Kahari V-M, and Heino J (1995). Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J Biol Chem 270: 13548–13552.
Roth T, Podesta F, Stepp MA, Boeri D, and Lorenzi M (1993). Integrin overexpression induced by high glucose and by human diabetes: Potential pathway to cell dysfunction in diabetic microangiopathy. Proc Natl Acad Sci USA 90: 9640–9644.
Rozzo C, Ratti P, Ponzoni M, and Cornaglia-Ferraris P (1993). Modulation of α1β1, α2β1 and α3β1 integrin heterodimers during human neuroblastoma cell differentiation. FEBS Lett 332: 263–267.
Ruoslahti E (1991). Integrins. J Clin Invest 87: 1–5.
Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, and Torok-Storb B (1994). HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48–57.
Schlaepfer DD, Hanks SK, Hunter T, and Geer PV (1994). Integrin-mediated signal transduction linked to Ras pathway by Grb2 binding to focal adhesion kinase. Nature 372: 786–791.
Seftor RE, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, and Hendrix MG (1992). Role of the αvβ3 integrin in human melanoma cell invasion. Proc Nat Acad Sci USA 89: 1557–1561.
Seftor RE, Seftor EA, Stetler-Stevenson WG, and Hendrix MG (1993). The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. Cancer Res 53: 3411–3415.
Setty S, Anderson SS, Wayner EA, Kim Y, Clegg DO, and Tsilibary EC (1995). Glucose-induced alteration of integrin expression and function in cultured human mesangial cells. Cell Adhes Commun 3: 187–200.
Simon EE and McDonald JA (1990). Extracellular matrix receptors in the kidney cortex. Am J Physiol 259: F783–F792.
Stanton H, Gavrilovic J, Atkinson SJ, d’Ortho M-P, Yamada KM, Zardi L, and Murphy G (1998). The activation of proMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci 111: 2789–2798.
Steffes MW, Bilous RW, Sutherland DER, and Mauer SM (1992). Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41: 679–684.
Steffes MW, Osterby R, Chavers B, and Mauer SM (1989). Mesangial expansion as a central mechanism for loss of kidney function in diabetes. Diabetes 38: 1077–1081.
Sugiura T and Berditchevski F (1999). Function of α3β1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J Cell Biol 146: 1375–1389.
Towbin H, Staehelin T, and Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci USA 76: 4350–4354.
Tremble P, Damsky CH, and Werb Z (1995). Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals. J Cell Biol 129: 1707–1720.
Tsilibary EC, Charonis AS, Reger LA, Wohlhueter RM, and Furcht LT (1988). The effect of nonenzymatic glycosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J Biol Chem 263: 4302–4308.
Waddell NJ (1956). A simple ultraviolet spectrophotometric method for the determination of protein. J Lab Clin Med 48: 311–314.
Wayner EA, Gil SG, Murphy GF, Wilke MS, and Carter WG (1993). Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for α3β1 positive T lymphocytes. J Cell Biol 121: 1141–1152.
Wayner EA, Orlando RA, and Cheresh DA (1991). Integrins αvβ3 and αvβ5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Cell Biol 113: 919–929.
Werb Z (1997). ECM and cell surface proteolysis: regulating cellular ecology. Cell 91: 439–442.
Werb Z, Tremble PM ., Behrendtsen O, Crowley E, and Damsky CH (1989). Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109: 877–889.
Wolf P (1983). A critical reappraisal of Waddell’s technique for ultraviolet spectrophotometric protein estimation. Anal Biochem 129: 145–155.
Wu K, Setty S, Mauer SM, Killen P, Nagase H, Michael AF, and Tsilibary EC (1997). Altered kidney matrix gene expression in early stages of experimental diabetes. Acta Anat 158: 155–165.
Xie B, Laouar A, and Huberman E (1998). Fibronectin-mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation. J Biol Chem 273: 11576–11582.
Ziyadeh FN (1993). Renal tubular basement membrane and collagen type IV in diabetes mellitus. Kidney Int 43: 114–120.
Acknowledgements
Supported by National Institutes of Health (Grant AI0708) and by the Greek GSRT/PENED-99 (Grant 174ED).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karamessinis, P., Tzinia, A., Kitsiou, P. et al. Proximal Tubular Epithelial Cell Integrins Respond to High Glucose by Altered Cell-Matrix Interactions and Differentially Regulate Matrixin Expression. Lab Invest 82, 1081–1093 (2002). https://doi.org/10.1097/01.LAB.0000022224.86237.31
Received:
Published:
Issue date:
DOI: https://doi.org/10.1097/01.LAB.0000022224.86237.31